Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 3, 2008, Pages 688-695

  Burt, Morton G ^a,b,c   Johannsson, Gudmundur ^a   Umpleby, A Margot ^d   Chisholm, Donald J ^a,b,c   Ho, Ken K Y ^a,b,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GROWTH HORMONE; LEUCINE; PRASTERONE; PREDNISONE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; OILY SKIN; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 40849140759     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2333     Document Type: Article

References (50)

1. Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM 1993 The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006
2. Kotler DP, Tierney AR, Wang J, Pierson Jr RN 1989 Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50:444-447
3. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F 2002 Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:809-813
4. Wajchenberg BL, Bosco A, Marone MM, Levin S, Rocha M, Lerario AC, Nery M, Goldman J, Liberman B 1995 Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab 80:2791-2794
5. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E 2001 Body composition and metabolic features inwomenwith adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 86:5301-5306
6. Burt MG, Gibney J, Ho KK 2006 Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clin Endocrinol (Oxf) 64:436-443
7. Ross EJ, Linch DC 1982 Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2:646-649
8. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C 2000 Use of oral corticosteroids in the United Kingdom. QJM 93:105-111
9. Walsh LJ, Wong CA, Pringle M, Tattersfield AE 1996 Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313:344-346
10. Beaufrere B, Horber FF, Schwenk WF, Marsh HM, Matthews D, Gerich JE, Haymond MW 1989 Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol 257(5 Pt 1):E712-E721
11. Horber FF, Haymond MW 1990 Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 86:265-272
12. Garrel DR, Moussali R, De Oliveira A, Lesiege D, Lariviere F 1995 RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism. J Clin Endocrinol Metab 80:379-385
13. Burt MG, Johannsson G, Umpleby AM, Chisholm DJ, Ho KK 2007 Impact of acute and chronic low-dose glucocorticoids on protein metabolism. J Clin Endocrinol Metab 92:3923-3929
14. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thomason M, Umpleby AM, Jones RH, Sonksen PH 1993 The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 38:427-431
15. Mauras N, O'Brien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL 2000 Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 85:1686-1694
16. Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D 1989 Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 66:498-503
17. Mauras N, Haymond MW, Darmaun D, Vieira NE, Abrams SA, Yergey AL 1994 Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone. J Clin Invest 93:1014-1019
18. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK 2005 Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289:E266-E271
19. Berneis K, Ninnis R, Girard J, Frey BM, Keller U 1997 Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man. J Clin Endocrinol Metab 82:2528-2534
20. Oehri M, Ninnis R, Girard J, Frey FJ, Keller U 1996 Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans. Am J Physiol 270(4 Pt 1):E552-E558
21. Attanasio AF, Bates PC, Ho KK, Webb SM, Ross RJ, Strasburger CJ, Bouillon R, Crowe B, Selander K, Valle D, Lamberts SW 2002 Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS Database. J Clin Endocrinol Metab 87:1600-1606
22. Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Rosen T, Thoren M, Bengtsson BA 1996 The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab 81:1575-1581
23. Feldt-Rasmussen U, Wilton P, Jonsson P, KIMS Study Group, KIMS International Board 2004 Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults. Growth Horm IGF Res 14(Suppl A):S51-S58
24. Holmes SJ, Shalet SM 1995 Which adults develop side-effects of growth hormone replacement? Clin Endocrinol (Oxf) 43:143-149
25. Burt MG, Gibney J, Hoffman DM, Umpleby AM, Ho KK 2007 Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults. Growth Horm IGF Res [Epub ahead of print]
26. Burt MG, Gibney J, Ho KK 2007 Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment. Am J Physiol Endocrinol Metab 292:E1426-E1432
27. Hoffman DM, Pallasser R, Duncan M, Nguyen TV, Ho KK 1998 How is whole body protein turnover perturbed in growth hormone-deficient adults? J Clin Endocrinol Metab 83:4344-4349
28. Schwenk WF, Beaufrere B, Haymond MW 1985 Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol 249(6 Pt 1):E646-E650
29. Horber FF, Horber-Feyder CM, Krayer S, Schwenk WF, Haymond MW 1989 Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis. Am J Physiol 257(3 Pt 1):E385-E399
30. Matthews DE, Motil KJ, Rohrbaugh DK, Burke JF, Young VR, Bier DM 1980 Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-3C]leucine. Am J Physiol 238:E473-E479
31. Ferrannini E 1988 The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301
32. Greenfield JR, Samaras K, Hayward CS, Chisholm DJ, Campbell LV 2005 Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab 90:661-672
33. O'Sullivan AJ, Kelly JJ, Hoffman DM, Freund J, Ho KK 1994 Body composition and energy expenditure in acromegaly. J Clin Endocrinol Metab 78:381-386
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
35. Tai MM 1994 A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152-154
36. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
37. Phillips DI, Clark PM, Hales CN, Osmond C 1994 Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292
38. Nissen SL, Van Huysen C, Haymond MW 1982 Measurement of branched chain amino acids and branched chain α-ketoacids in plasma by high-performance liquid chromatography. J Chromatogr 232:170-175
39. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW 1984 Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem 141:101-109
40. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK 1994 Diagnosis of growth-hormone deficiency in adults. Lancet 343:1064-1068
41. Bowes SB, Umpleby M, Cummings MH, Jackson NC, Carroll PV, Lowy C, Sonksen PH, Russell-Jones DL 1997 The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome. J Clin Endocrinol Metab 82:243-246
42. Bennet WM, Haymond MW 1992 Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment. Clin Endocrinol (Oxf) 36:161-164
43. Svensson J, Bengtsson BA 2003 Growth hormone replacement therapy and insulin sensitivity. J Clin Endocrinol Metab 88:1453-1454
44. Mauras N, Haymond MW 2005 Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 15:19-27
45. Norrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jorgensen JO, Christiansen JS, Moller N 2003 The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 88:4371-4378
46. Moller N, Copeland KC, Nair KS 2007 Growth hormone effects on protein metabolism. Endocrinol Metab Clin North Am 36:89-100
47. Christiansen JJ, Gravholt CH, Fisker S, Moller N, Andersen M, Svenstrup B, Bennett P, Ivarsen P, Christiansen JS, Jorgensen JO 2005 Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism. Eur J Endocrinol 152:77-85
48. Dhatariya K, Bigelow ML, Nair KS 2005 Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 54:765-769
49. Villareal DT, Holloszy JO 2004 Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292:2243-2248
50. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton 3rd LJ, Smith GE, Khosla S, Jensen MD 2006 DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647-1659